Related Experiment Video

Updated: Jun 28, 2025

Author Spotlight: FISH as a Tool for Precise Gene Amplification Assessment in Cancer Specimens
03:55

Author Spotlight: FISH as a Tool for Precise Gene Amplification Assessment in Cancer Specimens

Published on: July 12, 2024

1.3K

Tumor extrachromosomal DNA: Biogenesis and recent advances in the field

Haomin Wu1, Shiqi Liu1, Di Wu1

  • 1Department of General Surgery, the First Hospital of China Medical University, 155# Nanjing Street, Shenyang 110001, China.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|April 13, 2024
PubMed

Insights

Extrachromosomal DNA (ecDNA) amplifies oncogenes in tumors, driving cancer development and treatment resistance. This research explores ecDNA

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Extrachromosomal DNA (ecDNA) comprises self-replicating circular DNA molecules found outside the main chromosomes.
  • ecDNA contains regulatory elements and oncogenes, playing a role in malignant tumor progression.
  • The presence and amplification of oncogenes on ecDNA are linked to poor cancer prognosis.

Purpose of the Study:

  • To review recent advancements in understanding extrachromosomal DNA (ecDNA) in cancer.
  • To discuss the role of ecDNA in tumor development, heterogeneity, and treatment resistance.
  • To explore the potential of ecDNA as a cancer biomarker and therapeutic target.

Main Methods:

  • Literature review of recent studies on ecDNA in malignant tumors.
  • Analysis of ecDNA's structural features and their impact on oncogene amplification.
  • Examination of ecDNA's role in tumor cell heterogeneity and adaptation.
  • Discussion of current and potential clinical applications of ecDNA.

Main Results:

  • ecDNA significantly amplifies oncogenes, contributing to malignant tumor development.
  • Uneven ecDNA distribution during cell division increases tumor cell heterogeneity.
  • This heterogeneity enhances tumor adaptability and resistance to therapies.
  • ecDNA shows promise as a biomarker and therapeutic target in oncology.

Conclusions:

  • Extrachromosomal DNA (ecDNA) is a key driver of tumor progression and therapeutic challenges.
  • Understanding ecDNA mechanisms is crucial for developing novel cancer treatments.
  • ecDNA holds significant potential for clinical applications in cancer diagnosis and therapy.
Keywords:
ecDNA，tumor heterogeneity，drug resistance，biomarkers，genetics

More Related Videos

Genome-wide Purification of Extrachromosomal Circular DNA from Eukaryotic Cells14:26

Genome-wide Purification of Extrachromosomal Circular DNA from Eukaryotic Cells

Published on: April 4, 2016

25.2K
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.4K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K